Discipline of Pathology, Faculdade de Medicina do ABC, Santo André, SP, Brazil.
Instituto Médico Legal, São Paulo, SP, Brazil.
Rev Bras Ginecol Obstet. 2020 Jan;42(1):43-50. doi: 10.1055/s-0040-1701460. Epub 2020 Feb 27.
The present article aims to evaluate the impact of testosterone treatment on the expansion of visceral, subcutaneous and intramedullary adipose tissue of ovariectomized rats and the visceral and subcutaneous fat expression of peroxisome proliferator-activated receptors (PPARs) gamma METHODS: In total 48 female Wistar rats were castrated and randomly divided into 6 treatment groups: group E2 was submitted to estradiol 5 μg/day; group T, to testosterone 5 μg/day; group E2 + T, to estradiol 5 μg/day + testosterone 5 μg/day; group TT, to testosterone 30 μg/day; group E2 + TT, to estradiol 5 μg/day + testosterone 30 μg/day; and placebo was administered to group P. After 5 weeks, the rats were euthanized, the inguinal and visceral adipose tissues were harvested, weighted, and had their PPAR gamma expression evaluated by reverse transcription quantitative polymerase chain reaction (RT-qPCR). The right femurs were harvested and histologically prepared to perform the number count of the intramedullary adipocytes.
The expansion of visceral fat tissue was much higher in the TT group when compared with other treated groups ( < 0.001). The TT group also showed a higher expansion of inguinal fat ( < 0.01), and groups E2 + T and E2 + TT presented lower growth compared to the P group ( < 0.01). The number of femur intramedullary adipocytes only showed significant differences between groups TT and E2 + TT ( < 0.05). The expression of PPAR gamma showed no differences among the groups.
The use of testosterone in high doses leads to an important expansion in both visceral and inguinal adipose tissues. Association with estradiol exerts an expansion-repressive effect on the visceral and inguinal adipose tissues.
本文旨在评估睾丸激素治疗对去卵巢大鼠内脏、皮下和骨髓内脂肪组织扩张以及过氧化物酶体增殖物激活受体(PPARs)γ在内脏和皮下脂肪表达的影响。
将 48 只雌性 Wistar 大鼠去势,并随机分为 6 个治疗组:E2 组给予雌二醇 5μg/天;T 组给予睾丸酮 5μg/天;E2+T 组给予雌二醇 5μg/天+睾丸酮 5μg/天;TT 组给予睾丸酮 30μg/天;E2+TT 组给予雌二醇 5μg/天+睾丸酮 30μg/天;P 组给予安慰剂。5 周后,处死大鼠,采集腹股沟和内脏脂肪组织,称重,并通过逆转录定量聚合酶链反应(RT-qPCR)评估 PPARγ表达。采集右侧股骨并进行组织学准备,以进行骨髓内脂肪细胞计数。
与其他治疗组相比,TT 组的内脏脂肪组织扩张更为明显( < 0.001)。TT 组的腹股沟脂肪也有更高的扩张( < 0.01),E2+T 组和 E2+TT 组的生长速度低于 P 组( < 0.01)。仅 TT 组和 E2+TT 组的股骨骨髓内脂肪细胞数量存在显著差异( < 0.05)。各组之间 PPARγ 的表达无差异。
高剂量使用睾丸激素会导致内脏和腹股沟脂肪组织的重要扩张。与雌二醇联合使用对内脏和腹股沟脂肪组织有扩张抑制作用。